肝隧道技术:一种新型肝切除术的意向性治疗验证
这项前瞻性意向性治疗验证研究评估了肝隧道技术(LT)用于治疗具有≥1个深部中央位置肝脏肿瘤(伴或不伴肝中静脉侵犯)的患者。结果显示LT技术上可行且安全,无住院90天死亡率,总体并发症发生率为50%,主要并发症为10%,中位随访15个月仅观察到2例切缘局部复发。
要点
- LT技术适用于深部中央位置肝脏肿瘤,伴或不伴肝中静脉侵犯。
- 无住院90天死亡率,总体并发症50%,主要并发症10%,均保守处理。
核心结论
- 肝隧道技术技术上可行且安全,但需进一步研究标准化其使用。
主要发现
- 17例为结直肠癌肝转移,1例肝细胞癌,1例肿块型胆管癌,1例混合性肝细胞癌-肿块型胆管癌。
- 6例患者切除肝中静脉,均保留4i和5段。
- 共切除180个病灶(中位数7,范围1-37),其中79个病灶包含在肝隧道标本中(中位数3,范围1-13)。
- 无住院90天死亡率;总体并发症10例(50%),主要并发症2例(10%),所有并发症均保守处理。
临床怎么用
- 对于深部中央位置肝脏肿瘤患者,肝隧道技术可作为保留肝实质的术式选择。
- 若需切除肝中静脉,需注意保留4i和5段。
局限性
- 需进一步研究以标准化肝隧道技术的使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This prospective intention-to-treat validation study evaluated the liver tunnel (LT) technique for patients having ≥1 deep centrally located liver tumor, with or without middle hepatic vein (MHV) invasion. BACKGROUND: Conservative surgery has been proposed for patients with deep liver tumors having complex relationships. LT is one such novel technique. METHODS: Eligible patients were prospectively enrolled for LT. LT relies on tumor-vessel detachment, and the presence of communicating veins if MHV resection is necessary. RESULTS: Twenty consecutive patients met the inclusion criteria: 17 had colorectal liver metastases, 1 had hepatocellular carcinoma, 1 had mass-forming cholangiocarcinoma, and 1 had mixed hepatocellular carcinoma-mass-forming cholangiocarcinoma. Nineteen patients underwent LT. The MHV was resected in 6 patients, always sparing segments 4i and 5. Overall, 180 lesions were removed (median 7; range 1-37): 79 lesions were included in the LT specimen (median 3; range 1-13). There was no in-hospital 90-day mortality. Overall morbidity occurred in 10 (50%) patients: major in 2 (10%). All complications were managed conservatively. After a median 15-month follow-up (range 6-48), 2 instances of cut-edge local recurrences were observed. CONCLUSIONS: This study shows that LT is technically feasible and safe. Further studies are needed for standardizing its use.
引用
- Torzilli G, Procopio F, Viganò L, et al. The Liver Tunnel: Intention-to-treat Validation of a New Type of Hepatectomy. Ann Surg. 2019. PMID: 28902667. doi:10.1097/SLA.0000000000002509
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。